Meladrazine: Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
Rabin Bista (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
| IUPAC_name | | Watchedfields = changed | ||
| image | | verifiedrevid = 444563231 | ||
| IUPAC_name = ''N''<sup>2</sup>,''N''<sup>2</sup>,''N''<sup>4</sup>,''N''<sup>4</sup>-Tetraethyl-6-hydrazinyl-1,3,5-triazine-2,4-diamine | |||
| image = Meladrazine wiki str.png | |||
<!--Clinical data--> | |||
| tradename = | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 --> | |||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> | |||
| | | legal_UK = <!-- GSL / P / POM / CD / Class A, B, C --> | ||
| pregnancy_AU | | legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> | ||
| pregnancy_US | | legal_status = | ||
| pregnancy_category= | | routes_of_administration = | ||
| legal_AU | |||
| legal_CA | <!--Pharmacokinetic data--> | ||
| legal_UK | | bioavailability = | ||
| legal_US | | protein_bound = | ||
| legal_status = | | metabolism = | ||
| | | elimination_half-life = | ||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number = 13957-36-3 | |||
| ATC_prefix = G04 | |||
| ATC_suffix = BD03 | |||
| PubChem = 71679 | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} | |||
| DrugBank = | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 2V6Z0JG2X0 | |||
| KEGG_Ref = {{keggcite|correct|kegg}} | |||
| KEGG = D07225 | |||
| ChemSpiderID = 64733 | |||
<!--Chemical data--> | |||
| C=11 | H=23 | N=7 | |||
| molecular_weight = 253.347 g/mol | |||
| smiles = CCN(CC)C1=NC(=NN)N=C(N1)N(CC)CC | |||
| InChI = 1/C11H23N7/c1-5-17(6-2)10-13-9(16-12)14-11(15-10)18(7-3)8-4/h5-8,12H2,1-4H3,(H,13,14,15,16) | |||
| InChIKey = IRQOBYXMACIFKD-UHFFFAOYAO | |||
| StdInChI = 1S/C11H23N7/c1-5-17(6-2)10-13-9(16-12)14-11(15-10)18(7-3)8-4/h5-8,12H2,1-4H3,(H,13,14,15,16) | |||
| StdInChIKey = IRQOBYXMACIFKD-UHFFFAOYSA-N | |||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | |||
== Overview == | |||
'''Meladrazine''' is a drug used in [[urology]] as an [[antispasmodic]]. | '''Meladrazine''' is a drug used in [[urology]] as an [[antispasmodic]]. | ||
{{Urologicals}} | {{Urologicals}} | ||
[[Category:drug]] | |||
[[Category:Triazines]] | |||
[[Category:Hydrazines]] | |||
{{ | {{genito-urinary-drug-stub}} | ||
Revision as of 16:16, 15 April 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C11H23N7 |
Molar mass | 253.347 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Meladrazine |
Articles |
---|
Most recent articles on Meladrazine Most cited articles on Meladrazine |
Media |
Powerpoint slides on Meladrazine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Meladrazine at Clinical Trials.gov Clinical Trials on Meladrazine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Meladrazine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Meladrazine Discussion groups on Meladrazine Patient Handouts on Meladrazine Directions to Hospitals Treating Meladrazine Risk calculators and risk factors for Meladrazine
|
Healthcare Provider Resources |
Causes & Risk Factors for Meladrazine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Meladrazine is a drug used in urology as an antispasmodic.